{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T12:55:26Z","timestamp":1791550526032,"version":"4.3.4"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Protein Expression and Purification"],"published-print":{"date-parts":[[2027,2]]},"DOI":"10.1016\/j.pep.2026.107007","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T07:11:09Z","timestamp":1790147469000},"page":"107007","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A process selection framework for purifying rat IgG1 monoclonal antibodies from hybridoma culture supernatants: CaptureSelect IgG-Fc for speed and POROS 50 HS\u2013Capto Q for scale"],"prefix":"10.1016","volume":"244","author":[{"given":"Robert","family":"Clifford","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reena","family":"Varkey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4169-3611","authenticated-orcid":false,"given":"Chien-ying","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charan","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"O'Connor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pep.2026.107007_bib1","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.535","article-title":"The pharmacology and therapeutic applications of monoclonal antibodies","author":"Castelli","year":"2019","journal-title":"Pharmacol. Res. Perspect."},{"key":"10.1016\/j.pep.2026.107007_bib2","first-page":"9","article-title":"Monoclonal antibodies: a tool in clinical research","volume":"4","author":"Ansar","year":"2013","journal-title":"ICM"},{"key":"10.1016\/j.pep.2026.107007_bib3","article-title":"A comprehensive review of monoclonal antibodies in modern medicine: tracing the evolution of a revolutionary therapeutic approach","volume":"16","author":"Kothari","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.pep.2026.107007_bib4","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1177\/014107680509800403","article-title":"Therapeutic monoclonal antibodies in oncology","volume":"98","author":"Levene","year":"2005","journal-title":"J. R. Soc. Med."},{"key":"10.1016\/j.pep.2026.107007_bib5","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/256495a0","article-title":"Continuous cultures of fused cells secreting antibody of predefined specificity","volume":"256","author":"K\u00f6hler","year":"1975","journal-title":"Nature"},{"key":"10.1016\/j.pep.2026.107007_bib6","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/276269a0","article-title":"A better cell line for making hybridomas secreting specific antibodies","volume":"276","author":"Shulman","year":"1978","journal-title":"Nature"},{"key":"10.1016\/j.pep.2026.107007_bib7","doi-asserted-by":"crossref","first-page":"90","DOI":"10.2144\/btn-2019-0054","article-title":"Hybridoma technology: the preferred method for monoclonal antibody generation for in vivo applications","volume":"67","author":"Zaroff","year":"2019","journal-title":"Biotechniques"},{"key":"10.1016\/j.pep.2026.107007_bib8","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s43141-021-00264-6","article-title":"Hybridoma technology; advancements, clinical significance, and future aspects","volume":"19","author":"Mitra","year":"2021","journal-title":"J. Genet. Eng. Biotechnol."},{"key":"10.1016\/j.pep.2026.107007_bib9","doi-asserted-by":"crossref","first-page":"141","DOI":"10.5606\/fng.btd.2022.122","article-title":"Hybridoma technology for the production of monoclonal antibodies","volume":"8","author":"Sait","year":"2022","journal-title":"D. J. Med. Sci."},{"key":"10.1016\/j.pep.2026.107007_bib10","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1080\/19420862.2017.1331804","article-title":"Enhanced immunization techniques to obtain highly specific monoclonal antibodies","volume":"10","author":"de Almeida","year":"2018","journal-title":"mAbs"},{"key":"10.1016\/j.pep.2026.107007_bib11","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.it.2021.10.008","article-title":"Single B cell technologies for monoclonal antibody discovery","volume":"42","author":"Pedrioli","year":"2021","journal-title":"Trends Immunol."},{"key":"10.1016\/j.pep.2026.107007_bib12","article-title":"Generation of murine monoclonal antibodies by hybridoma technology","volume":"119","author":"Holzl\u00f6hner","year":"2017","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.pep.2026.107007_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106639","article-title":"Hybridoma technology a versatile method for isolation of monoclonal antibodies, its applications across species, limitations, advancement and future perspectives","volume":"85","author":"Parray","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.pep.2026.107007_bib14","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/ilar.46.3.258","article-title":"Monoclonal versus polyclonal antibodies: distinguishing characteristics, applications, and information resources","volume":"46","author":"Lipman","year":"2005","journal-title":"ILAR"},{"key":"10.1016\/j.pep.2026.107007_bib15","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/978-1-4939-8730-6_7","article-title":"Genome engineering of hybridomas to generate stable cell lines for antibody expression","volume":"1850","author":"Parola","year":"2018","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.pep.2026.107007_bib16","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.AID-0027-2014","article-title":"Use of human hybridoma technology to isolate human monoclonal antibodies","volume":"3","author":"Smith","year":"2015","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.pep.2026.107007_bib17","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/978-1-4684-4949-5_2","article-title":"Fusion partners for production of human monoclonal antibodies","author":"Kozbor","year":"1985","journal-title":"Hum. Antibodies Hybridomas"},{"key":"10.1016\/j.pep.2026.107007_bib18","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1073\/pnas.0305834101","article-title":"Hybridoma-free generation of monoclonal antibodies","volume":"101","author":"Pasqualini","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.pep.2026.107007_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0252558","article-title":"A hybridoma-derived monoclonal antibody with high homology to the aberrant myeloma light chain","volume":"16","author":"Pornnoppadol","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.pep.2026.107007_bib20","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1002\/bit.10493","article-title":"Transfection of NS0 myeloma fusion partner cells with HSP70 gene results in higher hybridoma yield by improving cellular resistance to apoptosis","volume":"81","author":"Lasunskaia","year":"2003","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.pep.2026.107007_bib21","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/978-1-62703-992-5_4","article-title":"Hybridoma technology for the generation of rodent mAbs via classical fusion","volume":"1131","author":"Chronopoulou","year":"2014","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.pep.2026.107007_bib22","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1073\/pnas.84.5.1374","article-title":"Identification of a monoclonal antibody specific for a murine T3 polypeptide","volume":"84","author":"Leo","year":"1987","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.pep.2026.107007_bib23","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.4049\/jimmunol.1203041","article-title":"High-affinity IgG antibodies develop naturally in Ig-knockout rats carrying germline human IgH\/Ig\u03ba\/Ig\u03bb loci bearing the rat CH region","volume":"190","author":"Osborn","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.pep.2026.107007_bib24","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/978-1-4612-4826-2_18","article-title":"Rat-rat hybridoma formation and rat monoclonal antibodies","volume":"7","author":"Bazin","year":"1987","journal-title":"Methods of Hybridoma Formation"},{"key":"10.1016\/j.pep.2026.107007_bib25","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/BF01315059","article-title":"Rat hybridoma antibodies against canine parvovirus","volume":"71","author":"Burtonboy","year":"1987","journal-title":"Arch. Virol."},{"key":"10.1016\/j.pep.2026.107007_bib26","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/eji.1830040112","article-title":"Three classes and four (sub)classes of rat immunoglobulins: igm, IgA, IgE and IgG1, IgG2a, IgG2b, IgG2c","volume":"4","author":"Bazin","year":"1974","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.pep.2026.107007_bib27","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.3109\/13880209.2011.653493","article-title":"Separation of antigens and antibodies by immunoaffinity chromatography","volume":"50","author":"Sheng","year":"2012","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.pep.2026.107007_bib28","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/0167-5699(83)90013-0","article-title":"Advantages of rat monoclonal antibodies","volume":"4","author":"Clark","year":"1983","journal-title":"Immunol. Today"},{"key":"10.1016\/j.pep.2026.107007_bib29","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3103\/S0891416822020082","article-title":"Production and characterization of rat monoclonal antibodies against the PAL antigen of Legionella spp","volume":"37","author":"Zeninskaya","year":"2022","journal-title":"Mol. Genet. Microbiol. Virol."},{"key":"10.1016\/j.pep.2026.107007_bib30","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jchromb.2006.09.030","article-title":"Protein A chromatography for antibody purification","volume":"848","author":"Hober","year":"2007","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.pep.2026.107007_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/ma9120994","article-title":"Fc-binding ligands of immunoglobulin G: an overview of high affinity proteins and peptides","volume":"9","author":"Choe","year":"2016","journal-title":"Materials"},{"key":"10.1016\/j.pep.2026.107007_bib32","doi-asserted-by":"crossref","first-page":"10240","DOI":"10.1016\/S0021-9258(18)67515-5","article-title":"A physicochemical study of protein G, a molecule with unique immunoglobulin G-binding properties","volume":"261","author":"Akerstr\u00f6m","year":"1986","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pep.2026.107007_bib33","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.4049\/jimmunol.135.4.2589","article-title":"Protein G: a powerful tool for binding and detection of monoclonal and polyclonal antibodies","volume":"135","author":"Akerstr\u00f6m","year":"1985","journal-title":"J. Immunol."},{"key":"10.1016\/j.pep.2026.107007_bib34","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1006\/jmbi.1994.1691","article-title":"The third IgG-binding domain from streptococcal protein G an analysis by x-ray crystallography of the structure alone and in a complex with fab","volume":"243","author":"Derrick","year":"1994","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.pep.2026.107007_bib35","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0161-5890(82)90253-X","article-title":"Fractionation of rat IgG subclasses and screening for IgG Fc-binding to bacteria","volume":"19","author":"Nilsson","year":"1982","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.pep.2026.107007_bib36","doi-asserted-by":"crossref","first-page":"969","DOI":"10.4049\/jimmunol.133.2.969","article-title":"Purification and some properties of streptococcal protein G, a novel IgG-binding reagent","volume":"133","author":"Bj\u00f6rck","year":"1984","journal-title":"J. Immunol."},{"key":"10.1016\/j.pep.2026.107007_bib37","article-title":"Purification of immunoglobulin G","volume":"21","author":"Andrew","year":"1997","journal-title":"Curr. Protoc. Im."},{"key":"10.1016\/j.pep.2026.107007_bib38","doi-asserted-by":"crossref","first-page":"140","DOI":"10.4049\/jimmunol.104.1.140","article-title":"Phylogenetic insight into evolution of mammalian fc fragment of \u03b3G globulin using staphylococcal Protein A","volume":"104","author":"Kronvall","year":"1970","journal-title":"J. Immunol."},{"key":"10.1016\/j.pep.2026.107007_bib39","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0022-1759(83)90251-X","article-title":"Different protein A immunosorbents may have different binding specificity for rat immunoglobulins","volume":"62","author":"Nilsson","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.pep.2026.107007_bib40","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/0019-2791(75)90146-9","article-title":"Rat immunoglobulins in serum and secretions: purification of rat IgM, IgA and IgG and their quantitation in serum, colostrum, milk and saliva","volume":"12","author":"McGhee","year":"1975","journal-title":"Immunochemistry"},{"key":"10.1016\/j.pep.2026.107007_bib41","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/0161-5890(81)90035-3","article-title":"Rat IgG subclasses: differences in affinity to protein-A sepharose","volume":"18","author":"Rousseaux","year":"1981","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.pep.2026.107007_bib42","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1365-3083.1979.tb03174.x","article-title":"Interactions between mouse immunoglobulins and staphylococcal protein A","volume":"9","author":"Chalon","year":"1979","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.pep.2026.107007_bib43","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/0076-6879(86)21063-0","article-title":"Purification of rat monoclonal antibodies","volume":"121","author":"Bazin","year":"1986","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.pep.2026.107007_bib44","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/protein\/15.10.835","article-title":"Engineering streptococcal protein G for increased alkaline stability","volume":"15","author":"G\u00fclich","year":"2002","journal-title":"Protein Eng."},{"key":"10.1016\/j.pep.2026.107007_bib45","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1042\/bj2740503","article-title":"The secondary structure of protein G, a robust molecule","volume":"274","author":"Goward","year":"1991","journal-title":"Biochem. J."},{"key":"10.1016\/j.pep.2026.107007_bib46","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0969-2126(01)00157-5","article-title":"Crystal structure of the C2 fragment of streptococcal protein G in complex with the Fc domain of human IgG","volume":"3","author":"Sauer-Eriksson","year":"1995","journal-title":"Structure"},{"key":"10.1016\/j.pep.2026.107007_bib47","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/protein\/gzu005","article-title":"An improved protein G with higher affinity for human\/rabbit IgG Fc domains exploiting a computationally designed polar network","volume":"4","author":"Jha","year":"2014","journal-title":"Protein Eng Des Sel"},{"key":"10.1016\/j.pep.2026.107007_bib48","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1042\/bj3400193","article-title":"Interactions between a single immunoglobulin-binding domain of protein L from Peptostreptococcus Magnus and a human \u03ba light chain","volume":"340","author":"Beckingham","year":"1999","journal-title":"Biochem. J."},{"key":"10.1016\/j.pep.2026.107007_bib49","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1365-3083.1993.tb03310.x","article-title":"On the interaction between protein L and immunoglobulins of various mammalian species","volume":"37","author":"De Ch\u00e2teau","year":"1993","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.pep.2026.107007_bib50","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0022-1759(84)90337-5","article-title":"Rat monoclonal antibodies. I. Rapid purification from in vitro culture supernatants","volume":"66","author":"Bazin","year":"1984","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.pep.2026.107007_bib51","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0022-1759(84)90200-X","article-title":"Rat monoclonal antibodies. II. A rapid and efficient method of purification from ascitic fluid or serum","volume":"71","author":"Bazin","year":"1984","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.pep.2026.107007_bib52","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1089\/hyb.1997.16.381","article-title":"Rapid development of affinity matured monoclonal antibodies using RIMMS","volume":"16","author":"Kilpatrick","year":"1997","journal-title":"Hybridoma"},{"key":"10.1016\/j.pep.2026.107007_bib53","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1080\/19420862.2017.1417717","article-title":"Integrated flow-through purification for therapeutic monoclonal antibodies processing","volume":"10","author":"Ichihara","year":"2018","journal-title":"mAbs"},{"key":"10.1016\/j.pep.2026.107007_bib54","article-title":"Protein posttranslational modifications in health and diseases: functions, regulatory mechanisms, and therapeutic implications","volume":"4","author":"Zhong","year":"2020","journal-title":"MedComm"},{"key":"10.1016\/j.pep.2026.107007_bib55","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/JLB.4A1219-078R","article-title":"Rat IgG mediated circulatory cell depletion in mice requires mononuclear phagocyte system and is facilitated by complement","volume":"107","author":"Sun","year":"2020","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.pep.2026.107007_bib56","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0217061","article-title":"Pharmacokinetic comparison of a diverse panel of non-targeting human antibodies as matched IgG1 and IgG2 isotypes in rodents and non-human primates","volume":"14","author":"Walker","year":"2019","journal-title":"PLoS One"}],"container-title":["Protein Expression and Purification"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1046592826001300?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1046592826001300?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T12:29:09Z","timestamp":1791548949000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1046592826001300"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,2]]},"references-count":56,"alternative-id":["S1046592826001300"],"URL":"https:\/\/doi.org\/10.1016\/j.pep.2026.107007","relation":{},"ISSN":["1046-5928"],"issn-type":[{"value":"1046-5928","type":"print"}],"subject":[],"published":{"date-parts":[[2027,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A process selection framework for purifying rat IgG1 monoclonal antibodies from hybridoma culture supernatants: CaptureSelect IgG-Fc for speed and POROS 50 HS\u2013Capto Q for scale","name":"articletitle","label":"Article Title"},{"value":"Protein Expression and Purification","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pep.2026.107007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107007"}}